Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
even with all the close knowledge and analysis all shares are a bet, decide your own odds, l am holding steady
The ERF was partly complete and paid for before the change of contractor, so Interserve have provisioned for the additional costs of delays to the build and necessary changes in original design to commission correctly. Interserve revised this provision twice from the original �90M for all the ERW exits.
so the Motley Fool got the sell message totally wrong, again!
obscured by the current news volatility are the success and completions of major contracts like York Uni etc. The employees deserve some support!
What is the thoughts on the 4.7M shares sell at 16.37?
I bought more in at this level, cheap given the solid business and new Viridor EFW' plants on progress to generate this year on, the political uncertainty alone does not touch the waste side of the business. I have done the same with IRV as their exit from the EFW is clearer too.
Emerald have sound international investment backers and have a strong track record. The result will be tight direction and actions by the Interserve BoD's in line with the debt holders which may be not in the shareholders future interest of course. Still continuing uncertainty for employees though until BoD's communicate! The good thing is there is value in there where commentators and banks are wary. I will hold and may add tomorrow.
Bought back in and I will hold on whatever, measured gamble as the exiting from the EFW and debt position is clearer.
I read this to suggest that IRV has had a problem with stage or completion certificates being signed off when they were not fully completed or why re validate?
IRV in talks with the banks again and so soon after last time. With the final liabilities on the EFW contracts not clear then there could be a new bottom SP. I am not buying back in yet.
Make if you can in this volatile share, I am awaiting the real position on many contracts and the EFW liabilities. It is a big hurdle and I would not rule out more debt positions. I am staying clear for now.
I hope you are all right about the rise and you don't lose money but much of their insurance cover could be void. If they didn't understand the business by getting into it how do they know anything better now? Roll on 2018, not in my portfolio anymore.
It looks brighter for the employees than shareholders to me, at least the work still needs to be done by someone. I did estimate that the exiting from EFW could touch £300M and now Interserve continue to withhold the apt of banking supervision, now exiting costs will exceed £160M and no clear timeframe to the exit process, which should have been clear by now. I can only continue to conclude tha tthe Interserve Board don't have a clue about the real timeframe or a handle on their liabilities. It looks like there could be further delays in commissioning the contracts they are mired in. I won't be buying back in and the £300M might not be enough if they cannot exit on time?
Agree, worth a punt if they do and await better liability forecast from the EFW business. There is a lack of trust here by IRV and this has such a large impact on the medium term share price.
Look at many times they get calls wrong, including Hedge Funds. Don't react to sheepdogs or be a sheep.
He has a valid view of IRV management knowing the recent contract positions and are, as before, delaying and lacking trust in the communications. I wonder if the bank consortium trust them?
More contract news but more risk and with margins unable to cover the debt pile?. Stay clear unless you can dip in and out short term, suspect there's little truth from IRV until the press let us know.
The extent is still being reviewed by IRV and at �195M there are still liabilities that could extend into 2019. Confidence in IRV management projections continue to alarm me and I will await the next provision update, or update from EY - no buy at present